VanEck Vectors Morningstar Durable Dividend ETF DURA 深 沪
已收盘 08-07 16:00:00 美东时间
38.853
+0.234
+0.60%
华盛通- 最 高38.88
- 今 开38.50
- 成交量 2032股
- 最 低 38.50
- 昨 收 38.6195
- 总市值 3885.30万
- 52周最高 39.42
- 市盈率 静 --
- 换手率 0.20%
- 52周最低 30.3662
- 委 比 7.14%
- 总股本 100.00万
- 历史最高 39.42
- 量 比 0.61
- 振 幅 0.98%
- 历史最低 13.049
- 每 手 1
- 风险率 2.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多EyePoint rises after enrollment update on Duravyu late-stage trials
Shares of EyePoint (EYPT) gained on Thursday after the company said that two late-stage trials for its lead asset, Duravyu, completed enrollments ahead of schedule, validating its confidence in the pr...
07-31 01:52
EyePoint completes Phase 3 DURAVYU enrollment for DME
EyePoint Pharmaceuticals ( ($EYPT) ) has provided an announcement. On July 30, ...
07-30 19:29
EyePoint to pay $4.6M to settle with DoJ over kickback claims
The U.S. Department of Justice announced on Friday that EyePoint Pharmaceuticals (EYPT) agreed to pay $4.6M to resolve allegations that the company paid kickbacks to certain healthcare providers to bo...
07-17 23:13
BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts As Board Director
BrainStorm Cell Therapeutics Inc. (OTCQB:BCLI), a leading developer of autologous stem cell therapies for neurodegenerative diseases, today announced that Peter J. Pitts has been appointed to the Company's Board of
05-28 19:49
EyePoint Pharma Bets Big on DURAVYU Pivotal Data
Eyepoint Pharma (($EYPT)) has held its Q1 earnings call. Read on for the main h...
05-20 11:18
EyePoint Pharma Bets on DURAVYU Amid Mounting Losses
Eyepoint Pharma (($EYPT)) has held its Q1 earnings call. Read on for the main h...
05-08 10:20
